Pharmaceuticals News and Research

RSS

Study provides first formal analysis of comparative effectiveness research on new therapies

An analysis by researchers at the Keck School of Medicine of the University of Southern California has found that only 32 percent of medication studies published in top medical journals compare the effectiveness of existing treatments. These studies, known as comparative effectiveness studies, help doctors know which therapies work best and under what circumstances they are most effective.

10 Mar 2010

Bayer's bioequivalence study comparing Adalat XL to Mylan-Nifedipine Extended Release flawed, says Mylan

Mylan today reported that it has identified multiple flaws within a purported bioequivalence study sponsored by Bayer Inc. of Canada. The study compared Bayer's antihypertensive Adalat(R) XL(R) tablets, 60 mg, marketed in Canada, to Mylan's approved generic version, Mylan-Nifedipine Extended Release tablets, 60 mg, marketed in Canada.

10 Mar 2010

Integrated public and investor relations healthcare and life sciences practice launched

Feintuch Communications, Inc. (www.feintuchcommunications.com) has created an integrated public and investor relations healthcare and life sciences practice, naming Jules Abraham as vice president of the firm and managing director of the new group.

10 Mar 2010

Corporate Translations switches to Across Language Server for translation management software

Corporate Translations, Inc., a leading translation service provider specializing in the life science industry, has recently switched from Trados to the Across Language Server for its translation management software. The company indicates that the Across technology better meets its core values of speed, accuracy, flexibility and innovation; Corporate Translations will move all of its suitable translation projects to the Across Language Server over the course of 2010.

10 Mar 2010

Winners of NMSIS scholarship award

Two winners have been selected for the Promising New Investigators Travel Scholarship Awards given annually by the Neuroleptic Malignant Syndrome Information Service (NMSIS).

10 Mar 2010

Lonza acquires access to PCA technology patent portfolio

Odyssey Thera, Inc., announced today the signing of an agreement with Lonza to make Odyssey Thera's proprietary Protein-fragment Complementation Assay (PCA) technology, as part of compound profiling services, available to life science and drug discovery researchers.

10 Mar 2010

Celltrion develops novel human monoclonal antibodies against influenza virus infection

Celltrion, Inc., a South Korean biopharmaceutical company, has developed novel human monoclonal antibodies against influenza virus infection, which neutralize a broad spectrum of influenza viruses, including pandemic H1N1 and the deadly H5N1 avian influenza virus. Preliminary tests in laboratory animals indicate that the novel human monoclonal antibodies can be used to prevent disease when given either before or after infection.

10 Mar 2010

Aton Pharma introduces authorized generic version of Timoptic-XE

Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that it has launched an authorized generic version of its Timoptic-XE® (timolol maleate ophthalmic gel forming solution). Timoptic-XE is a non-selective beta-adrenergic receptor blocking agent indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Aton also announced that it will continue to make available branded Timoptic-XE.

9 Mar 2010

Abbott announces definitive agreement to acquire Facet Biotech

Abbott and Facet Biotech Corporation announced today a definitive agreement for Abbott to acquire Facet, enhancing Abbott's early- and mid-stage pharmaceutical pipeline.

9 Mar 2010

Bioniche Pharma introduces Mefoxin in frozen premix bags

Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals, announced today the launch of Mefoxin® (cefoxitin injection) frozen premix bags. The launch marks the company's first product offering to be supplied in a frozen premix bag presentation. Mefoxin (cefoxitin injection) is manufactured by Baxter Healthcare Corporation using Baxter's proprietary GALAXY container technology.

9 Mar 2010

EUCODIS Bioscience introduces phospholipases

EUCODIS Bioscience, a company providing customized enzymes to the pharmaceutical, chemical, and other industries, announced today that it has launched a panel of phospholipases, adding a new enzyme family to its product portfolio.

9 Mar 2010

Orexigen Therapeutics reports net loss of $15.0M for three months ended December 31, 2009

Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the three months and year ended December 31, 2009.

9 Mar 2010

MicroConstants acquires access to new nanosizing technology

MicroConstants, a GLP-compliant Contract Research Organization specializing in bioanalytical and pharmacokinetic analysis, has acquired access to a new nanosizing technology that transforms water insoluble compounds into nanoparticles, making formulation preparation and dosing for toxicology studies easier.

9 Mar 2010

March designated as 'National Autoimmune Diseases Awareness Month'

On the evening of March 4, 2010, the U.S. Senate passed a resolution designating March as "National Autoimmune Diseases Awareness Month" and supporting efforts to increase awareness of autoimmune diseases and increase funding for autoimmune disease research. The Senate resolution (S.RES.372) was introduced by Michigan Senator Carl Levin on December 8, 2009.

9 Mar 2010

Pharmaceutical Institute announces the release of Therapeutic Area Essentials

Pharmaceutical Institute, a leading provider of specialized training solutions for the pharmaceutical and biotech industry and a subsidiary of Campbell Alliance, today announced the release of Therapeutic Area Essentials™, a comprehensive suite of more than 155 therapeutic area e-courses covering diagnosis, cause, and treatment for over 40 disease states.

9 Mar 2010

Ingenuity Systems announces Molecule Scientific as exclusive distributor of IPA in Taiwan

Ingenuity Systems, the leading provider of information solutions for life science researchers, today announced Molecule Scientific Co., Ltd. as the exclusive distributor of IPA® in Taiwan.

9 Mar 2010

Sartorius achieves operating earnings of 60.9M euros for 2009

Sartorius, a leading international laboratory and process equipment provider, increased its operating profit in 2009 despite the difficult macroeconomic climate and achieved operating earnings of 60.9 million euros, up from 56.8 million euros a year earlier. “As a result, we are among the companies that were able to close the 2009 year of crisis with a positive development of operating earnings,” commented CEO Dr. Joachim Kreuzburg on the company’s full-year results at the annual press conference in Goettingen, Germany.

From Sartorius 9 Mar 2010

PAF launches resource directory to assist underinsured consumers

Patient Advocate Foundation (PAF) – a national non-profit organization that seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability relative to their diagnosis of life threatening or debilitating diseases – with the Patient Action Council Delegates, unveiled The National Underinsured Resource Directory, which is intended to help underinsured individuals and families locate important resources and seek alternative coverage options or methods to cover their healthcare needs.

9 Mar 2010

Growing human therapeutic proteins in algae can help reduce cancer treatment cost

Pharmaceutical companies could substantially reduce the expense of costly treatments for cancer and other diseases produced from mammalian or bacterial cells by growing these human therapeutic proteins in algae-rapidly growing aquatic plant cells that have recently gained attention for their ability to produce biofuels.

9 Mar 2010

Researchers examine benefits of collaboration between family physicians and community pharmacists

A research team from the Laval Centre de sant- et de services sociaux, Universit- de Montr-al and McGill University Health Centre has examined the benefits of greater collaboration between family physicians and community pharmacists for select patients.

9 Mar 2010

Pharmaceuticals News and Research

Study provides first formal analysis of comparative effectiveness research on new therapies

Bayer's bioequivalence study comparing Adalat XL to Mylan-Nifedipine Extended Release flawed, says Mylan

Integrated public and investor relations healthcare and life sciences practice launched

Corporate Translations switches to Across Language Server for translation management software

Winners of NMSIS scholarship award

Lonza acquires access to PCA technology patent portfolio

Celltrion develops novel human monoclonal antibodies against influenza virus infection

Aton Pharma introduces authorized generic version of Timoptic-XE

Abbott announces definitive agreement to acquire Facet Biotech

Bioniche Pharma introduces Mefoxin in frozen premix bags

EUCODIS Bioscience introduces phospholipases

Orexigen Therapeutics reports net loss of $15.0M for three months ended December 31, 2009

MicroConstants acquires access to new nanosizing technology

March designated as 'National Autoimmune Diseases Awareness Month'

Pharmaceutical Institute announces the release of Therapeutic Area Essentials

Ingenuity Systems announces Molecule Scientific as exclusive distributor of IPA in Taiwan

Sartorius achieves operating earnings of 60.9M euros for 2009

PAF launches resource directory to assist underinsured consumers

Growing human therapeutic proteins in algae can help reduce cancer treatment cost

Researchers examine benefits of collaboration between family physicians and community pharmacists

Free eBook - From lab to market: Accelerate your bioprocessing journey eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring